GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 90,000 | $295,200 | 0.31% |
| Greenlight Capital | 588,410 | $1,929,985 | 0.11% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $190,568 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,100 | $148,903 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 2,500 | $8,200 | 0.00% |
| OSAIC HOLDINGS, INC. | 10,000 | $32,800 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,476 | $489,355 | 0.00% |
| BlackRock Inc. | 27,925 | $91,594 | 0.00% |
| Citadel Advisors | 1,700 | $5,491 | 0.00% |
| Citadel Advisors | 4,100 | $13,243 | 0.00% |